Does vitamin D supplementation improve alopecia?

Does Vitamin D Help Alopecia?

While vitamin D deficiency is consistently associated with alopecia areata, the evidence for vitamin D supplementation as a treatment remains limited and inconsistent—however, checking vitamin D levels and correcting deficiency is reasonable, particularly in patients with documented low levels, as topical vitamin D analogs show modest efficacy in mild-to-moderate patchy disease.

The Association Between Vitamin D and Alopecia

Multiple case-control studies demonstrate a clear association between low vitamin D levels and alopecia areata (AA). Five case-control studies found that patients with AA have significantly lower serum 25(OH)D levels compared to controls, with vitamin D deficiency prevalence ranging from 42-91% in AA patients versus 25-33% in controls 1. The severity of hair loss inversely correlates with vitamin D levels—lower vitamin D corresponds to more extensive alopecia 1.

A 2024 meta-analysis of 3,374 non-scarring alopecia patients confirmed decreased serum 25(OH)D levels (mean difference -7.29 ng/mL) and a 3-fold increased incidence of vitamin D deficiency (OR 3.11) compared to healthy controls 2.

Critical Limitation of Association Studies

These studies cannot distinguish whether vitamin D deficiency is a cause or consequence of AA—psychosocial stress from hair loss may lead to sun avoidance and subsequent vitamin D deficiency 1. More importantly, the only prospective study of 55,929 women found no association between vitamin D intake, supplementation, or calculated vitamin D scores and the risk of developing incident AA 1. This suggests vitamin D deficiency may be an epiphenomenon rather than a causative factor.

The Biological Plausibility

Vitamin D plays an established role in hair follicle biology through the vitamin D receptor (VDR). Murine studies show that VDR knockout mice develop progressive alopecia, and humans with VDR gene mutations (vitamin D-dependent rickets type II) develop total scalp and body alopecia 1. However, critically, mice with undetectable circulating vitamin D but intact VDR did not develop alopecia, suggesting the VDR itself—not the vitamin D ligand—is more important for hair follicle function 1.

Treatment Evidence: Oral Supplementation

There are no randomized controlled trials evaluating oral vitamin D supplementation for alopecia treatment. The evidence is limited to:

• Case reports showing hair regrowth with vitamin D replacement in deficient patients 3
• A pediatric case combining vitamin D supplementation with dietary changes and multiple other nutrients, making it impossible to isolate vitamin D's effect 4

Treatment Evidence: Topical Vitamin D Analogs

The evidence for topical calcipotriol (vitamin D analog) is more substantial but still limited:

Studies Showing Benefit:

• A 2017 study of 22 patients with patchy AA treated with 0.005% calcipotriol twice daily showed 59.1% had hair regrowth, with onset at 4.2 weeks 1, 5. Patients with lowest baseline vitamin D levels had the greatest response 1.
• A Turkish study of 48 patients found 75% achieved ≥50% hair regrowth after 12 weeks of twice-daily calcipotriol 1
• A case report demonstrated complete regrowth in a 7-year-old with reduced VDR expression after 3 months of daily calcipotriol 1, 6

Critical Limitations:

• None of these studies included placebo controls, making interpretation difficult given that 34-80% of AA patients experience spontaneous recovery without treatment 1
• Two studies found no response to calcipotriol in patients with alopecia totalis/universalis 1

Meta-Analysis Findings:

A 2026 systematic review found the overall success rate of vitamin D3 and its analogs for mild-to-moderate AA is approximately 54% 7. Both intralesional and topical vitamin D3 showed efficacy (OR 3.20 for intralesional), with synergistic effects when combined with topical corticosteroids or NB-UVB 7. However, intralesional vitamin D3 was less effective than intralesional corticosteroids 7.

Clinical Recommendations

For Patients with Alopecia Areata:

1. Check serum 25(OH)D levels, particularly in patients with moderate-to-severe disease or those not responding to standard treatments

2. If vitamin D deficiency is documented (<20 ng/mL):

   • Correct the deficiency with standard supplementation (typically 1,000-2,000 IU daily or higher doses based on severity)
   • This is reasonable for general health regardless of hair outcomes

3. For mild-to-moderate patchy AA:

   • Consider topical calcipotriol 0.005% twice daily as an adjunctive treatment, particularly in vitamin D-deficient patients
   • Set realistic expectations: approximately 50-60% response rate in uncontrolled studies
   • Monitor for local side effects (irritation, pruritus, scaling, folliculitis)
   • Consider combining with topical corticosteroids for potentially synergistic effects 7

4. For severe AA (alopecia totalis/universalis):

   • Vitamin D analogs are unlikely to be effective as monotherapy 1
   • Focus on established treatments (JAK inhibitors, immunotherapy)

Important Caveats:

• Do not delay proven treatments (intralesional corticosteroids, topical immunotherapy, JAK inhibitors) in favor of vitamin D supplementation alone
• The association between vitamin D and AA does not prove causation
• Spontaneous remission is common in AA, making uncontrolled studies difficult to interpret
• No serious adverse events are associated with vitamin D analogs, making them a safe adjunctive option 7

Emerging Perspective:

A 2025 review suggests vitamin D may serve as an immunomodulator in AA, regulating follicular immune privilege, and that supplementation may reduce disease severity and relapse rates 8. However, this remains theoretical pending high-quality randomized controlled trials.

The bottom line: Vitamin D supplementation is reasonable in deficient patients but should not replace established AA treatments. Topical vitamin D analogs may serve as safe, inexpensive adjunctive therapy for mild-to-moderate patchy disease, particularly when combined with other treatments 7, 8.